AxoGen, Inc. (AXGN)
Company Info
Highlights
$517.50M
-$0.23
$145.96M
$109.36M
$7.80M
$5.65 - $21.00
$25.71
4.49%
3.66
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
AxoGen, Inc. (AXGN) returned -30.89% year-to-date (YTD) and 98.09% over the past 12 months. Over the past 10 years, AXGN delivered an annualized return of 13.98%, outperforming the S&P 500 benchmark at 10.69%.
AXGN
-30.89%
-28.32%
-18.47%
98.09%
6.61%
13.98%
^GSPC (Benchmark)
-0.64%
8.97%
-2.62%
11.90%
15.76%
10.69%
Monthly Returns
The table below presents the monthly returns of AXGN, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 10.50% | 9.88% | -7.55% | -12.05% | -29.99% | -30.89% | |||||||
| 2024 | 41.58% | 9.20% | -23.58% | -20.57% | 6.55% | 6.00% | 21.27% | 49.77% | 6.62% | -0.14% | -0.71% | 18.56% | 141.29% |
| 2023 | -5.11% | -12.88% | 14.55% | -4.55% | -5.76% | 7.41% | -5.37% | -27.55% | -20.13% | -24.80% | 74.20% | 4.27% | -31.56% |
| 2022 | -7.04% | 7.23% | -14.99% | -8.82% | 33.56% | -15.31% | 13.80% | 0.54% | 27.21% | -4.19% | -4.12% | -8.86% | 6.51% |
| 2021 | -3.07% | 27.38% | -8.33% | -7.60% | 8.44% | 6.45% | -5.74% | -16.25% | -7.39% | -3.86% | -37.00% | -2.09% | -47.65% |
| 2020 | -30.91% | 0.16% | -15.99% | -6.25% | -0.51% | -4.74% | 23.05% | 4.40% | -2.02% | 8.43% | 13.32% | 25.26% | 0.06% |
| 2019 | -19.24% | 11.88% | 14.08% | 11.49% | -10.86% | -5.40% | -9.19% | -11.85% | -21.26% | -0.32% | 39.31% | 3.23% | -12.43% |
| 2018 | -1.77% | 5.04% | 25.00% | 9.04% | 23.37% | 2.34% | -10.59% | -2.40% | -15.96% | 1.19% | -10.22% | -38.98% | -27.81% |
| 2017 | 21.11% | -4.13% | 0.00% | 16.75% | 21.72% | 12.79% | -5.67% | 11.39% | 9.94% | 6.20% | 29.93% | 5.99% | 214.44% |
| 2016 | -0.80% | 4.84% | 3.08% | 8.58% | -4.47% | 23.74% | -2.33% | 34.08% | 0.22% | -1.99% | -5.65% | 7.78% | 80.00% |
| 2015 | -4.18% | -7.85% | 10.41% | -2.86% | -10.00% | 2.61% | 9.24% | 38.48% | -13.26% | 12.86% | 18.28% | -9.09% | 39.28% |
| 2014 | -10.24% | 0.25% | -24.50% | -16.72% | -0.79% | 10.32% | -14.03% | 6.28% | -3.94% | 13.52% | 1.81% | 27.30% | -20.04% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 89, AXGN is among the top 11% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for AxoGen, Inc. (AXGN) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the AxoGen, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the AxoGen, Inc. was 98.50%, occurring on Aug 16, 2002. Recovery took 3701 trading sessions.
The current AxoGen, Inc. drawdown is 79.62%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -98.5% | Jun 10, 1996 | 1558 | Aug 16, 2002 | 3701 | May 1, 2017 | 5259 |
| -93.54% | Jul 24, 2018 | 1329 | Nov 1, 2023 | — | — | — |
| -52.46% | Aug 28, 1991 | 169 | Apr 28, 1992 | 750 | Apr 17, 1995 | 919 |
| -42.86% | Apr 30, 1990 | 183 | Jan 17, 1991 | 41 | Mar 18, 1991 | 224 |
| -40.35% | Apr 19, 1995 | 112 | Sep 26, 1995 | 176 | Jun 6, 1996 | 288 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of AxoGen, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Earnings Per Share
The chart presents the Earnings Per Share (EPS) performance of AxoGen, Inc., comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -225.0%.
Valuation
The Valuation section provides an overview of how AxoGen, Inc. is priced in the market compared to other companies in the Medical Devices industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for AXGN compared to other companies in the Medical Devices industry. AXGN currently has a PEG ratio of 0.0. This PEG ratio is low compared to industry peers, which could indicate the stock is undervalued relative to its expected growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for AXGN relative to other companies in the Medical Devices industry. Currently, AXGN has a P/S ratio of 2.7. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for AXGN in comparison with other companies in the Medical Devices industry. Currently, AXGN has a P/B value of 7.2. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |